Back to Journals » OncoTargets and Therapy » Volume 7

Original Research

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma

       
Total article views   HTML views PDF downloads Totals
10,582 Dovepress* 9,843+ 1,476 11,319
PubMed Central* 739 331 1,070
Totals 10,582 1,807 12,389
*Since 23 May 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar